CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 34 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,473,000 | +4.4% | 189,011 | +4.2% | 0.00% | 0.0% |
| Q3 2020 | $3,327,000 | +27.3% | 181,463 | +3.9% | 0.00% | 0.0% |
| Q2 2020 | $2,613,000 | +0.6% | 174,606 | +6.3% | 0.00% | 0.0% |
| Q1 2020 | $2,597,000 | -48.9% | 164,196 | -47.5% | 0.00% | 0.0% |
| Q4 2019 | $5,078,000 | +126.7% | 312,782 | +107.4% | 0.00% | 0.0% |
| Q3 2019 | $2,240,000 | -8.9% | 150,790 | +1.3% | 0.00% | 0.0% |
| Q2 2019 | $2,459,000 | +7.7% | 148,815 | +12.7% | 0.00% | 0.0% |
| Q1 2019 | $2,283,000 | -48.7% | 132,003 | -47.6% | 0.00% | 0.0% |
| Q4 2018 | $4,452,000 | +120.2% | 252,134 | +126.2% | 0.00% | 0.0% |
| Q3 2018 | $2,022,000 | +12.4% | 111,446 | +21.1% | 0.00% | 0.0% |
| Q2 2018 | $1,799,000 | +76.5% | 92,023 | +58.4% | 0.00% | – |
| Q1 2018 | $1,019,000 | +120.1% | 58,085 | +42.3% | 0.00% | – |
| Q4 2017 | $463,000 | +2.4% | 40,805 | -3.9% | 0.00% | – |
| Q3 2017 | $452,000 | +21.8% | 42,453 | 0.0% | 0.00% | – |
| Q2 2017 | $371,000 | -48.8% | 42,453 | -30.9% | 0.00% | – |
| Q1 2017 | $725,000 | -8.3% | 61,446 | +1.7% | 0.00% | – |
| Q4 2016 | $791,000 | -4.1% | 60,416 | +6.2% | 0.00% | – |
| Q3 2016 | $825,000 | +24.2% | 56,899 | +2.7% | 0.00% | – |
| Q2 2016 | $664,000 | -31.8% | 55,422 | +6.1% | 0.00% | -100.0% |
| Q1 2016 | $974,000 | -12.3% | 52,252 | +1.0% | 0.00% | 0.0% |
| Q4 2015 | $1,111,000 | +30.9% | 51,729 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $849,000 | -40.8% | 50,149 | +31.1% | 0.00% | 0.0% |
| Q2 2015 | $1,435,000 | +68.8% | 38,260 | +41.5% | 0.00% | – |
| Q1 2015 | $850,000 | +288.1% | 27,034 | +58.8% | 0.00% | – |
| Q4 2014 | $219,000 | – | 17,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|